Macquarie Group LTD Adma Biologics, Inc. Transaction History
Macquarie Group LTD
- $86.4 Billion
- Q4 2024
A detailed history of Macquarie Group LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 1,014,689 shares of ADMA stock, worth $18.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,014,689
Previous 1,138,323
10.86%
Holding current value
$18.7 Million
Previous $22.8 Million
23.53%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$344 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$335 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$274 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$208 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$102 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.62B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...